Headlines & Research Highlights
The clinical-stage oncology company and TRIUMF announced their entry into the next phase of their collaboration agreement for the production of actinium-225.
After 20 years of service to TRIUMF, Jens Dilling will be departing the laboratory on July 31, 2021 to take on a new challenge as the Director of Institutional Strategic Planning at Oak Ridge National Laboratory in Tennessee.
TRIUMF has joined RADNEXT (‘RADiation facility Network for the EXploration of effects for indusTry and research’), a Horizons 2020 infrastructure project that will establish a global network of facilities and related irradiation methodology for responding to the emerging needs of electronics component and system irradiation.
Effective today, TRIUMF has successfully completed its transition from a joint venture to a non-profit incorporation with charitable status.
The TRIUMF community would like to share a warm welcome for the lab’s next Director, Dr. Nigel Smith, whose 5-year term as TRIUMF Director begins today.